Ageing and Neurodegenerative Diseases
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Ageing and Neurodegenerative Diseases
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig1

From:  Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease
Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease

Figure 1. Schematic diagram of the molecular mechanisms of the plasminogen activator system. PAI-1: Plasminogen activator inhibitor-1; NSP: neuroserpin; uPA: urokinase-type plasminogen activator; tPA: tissue-type plasminogen activator; PLG: plasminogen; PLM: plasmin. Created with BioRender.com.

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/ageing-and-neurodegenerative-diseases

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties